Cargando…

Protecting the tuberculosis drug pipeline: stating the case for the rational use of fluoroquinolones

The use of fluoroquinolones (FQs) to treat lower respiratory tract infections (LTRI) other than tuberculosis (TB) allows selection of FQ-resistant TB when TB is misdiagnosed. This study maps national guidelines on the use of FQs for LRTI in Europe and determines the risk of FQ-resistant TB upon FQ t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Migliori, Giovanni Battista, Langendam, Miranda W., D'Ambrosio, Lia, Centis, Rosella, Blasi, Francesco, Huitric, Emma, Manissero, Davide, van der Werf, Marieke J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2012
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461345/ https://www.ncbi.nlm.nih.gov/pubmed/22653774 http://dx.doi.org/10.1183/09031936.00036812

Ejemplares similares

Knowledge of tuberculosis-treatment prescription of health workers: a systematic review
por: van der Werf, Marieke J., et al.
Publicado: (2012)

Multidrug resistance after inappropriate tuberculosis treatment: a meta-analysis
por: van der Werf, Marieke J., et al.
Publicado: (2012)

Tuberculosis transmission between foreign- and native-born populations in the EU/EEA: a systematic review
por: Sandgren, Andreas, et al.
Publicado: (2014)

Prevalence of inappropriate tuberculosis treatment regimens: a systematic review
por: Langendam, M.W., et al.
Publicado: (2012)

A new free-cost e-service supporting clinicians to manage their difficult-to-treat tuberculosis cases: The European Respiratory Society-World Health Organization tuberculosis Consilium
por: D’Ambrosio, Lia, et al.
Publicado: (2017)

New anti-tuberculosis drugs and regimens: 2015 update
por: D'Ambrosio, Lia, et al.
Publicado: (2015)

The definition of tuberculosis infection based on the spectrum of tuberculosis disease
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

International collaboration among medical societies is an effective way to boost Latin American production of articles on tuberculosis
por: Migliori, Giovanni Battista, et al.
Publicado: (2019)

Migration and medical screening for tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2023)

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Sotgiu, Giovanni, et al.
Publicado: (2016)

Recent developments in the diagnosis and management of tuberculosis
por: Sulis, Giorgia, et al.
Publicado: (2016)

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Migliori, Giovanni Battista, et al.
Publicado: (2017)

Tuberculosis and COVID-19, the new cursed duet: what differs between Brazil and Europe?
por: Silva, Denise Rossato, et al.
Publicado: (2021)

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline
por: Tadolini, Marina, et al.
Publicado: (2016)

Post-tuberculosis lung disease: a comparison of Brazilian, Italian, and Mexican cohorts
por: Silva, Denise Rossato, et al.
Publicado: (2022)

Post-tuberculosis sequelae and their socioeconomic consequences: worth investigating
por: Sotgiu, Giovanni, et al.
Publicado: (2021)

Tuberculosis elimination: where are we now?
por: Matteelli, Alberto, et al.
Publicado: (2018)

Is there a rationale for pulmonary rehabilitation following successful chemotherapy for tuberculosis?
por: Muñoz-Torrico, Marcela, et al.
Publicado: (2016)

Current use and acceptability of novel diagnostic tests for active tuberculosis: a worldwide survey
por: Amicosante, Massimo, et al.
Publicado: (2017)

Breathing Back Better! A State of the Art on the Benefits of Functional Evaluation and Rehabilitation of Post-Tuberculosis and Post-COVID Lungs
por: Pontali, Emanuele, et al.
Publicado: (2022)

The battle against colistin-resistant E. coli and the need for a one health approach
por: Danaei, Bardia, et al.
Publicado: (2023)

Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence
por: Migliori, Giovanni Battista, et al.
Publicado: (2021)

The association of SARS-CoV-2 infection and tuberculosis disease with unfavorable treatment outcomes: A systematic review
por: Vadlamudi, Nirma Khatri, et al.
Publicado: (2023)

Mandatory tuberculosis case notification in high tuberculosis-incidence countries: policy and practice
por: Uplekar, Mukund, et al.
Publicado: (2016)

The challenge of managing extensively drug-resistant tuberculosis at a referral hospital in the state of São Paulo, Brazil: a report of three cases
por: Arbex, Marcos Abdo, et al.
Publicado: (2015)

Minimum package for cross-border TB control and care in the WHO European region: a Wolfheze consensus statement
por: Dara, Masoud, et al.
Publicado: (2012)

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis
por: Maryandyshev, Andrey, et al.
Publicado: (2017)

Towards tuberculosis elimination: an action framework for low-incidence countries
por: Lönnroth, Knut, et al.
Publicado: (2015)

Management and outcomes of severe childhood tuberculosis in the pediatric intensive care setting: can we identify best practices?
por: Velizarova, Svetlana, et al.
Publicado: (2019)

Childhood tuberculosis: progress requires an advocacy strategy now
por: Sandgren, Andreas, et al.
Publicado: (2012)

Monitoring toxicity in individuals receiving treatment for latent tuberculosis infection: a systematic review versus expert opinion
por: Sotgiu, Giovanni, et al.
Publicado: (2015)

The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019
por: Pranger, A. D., et al.
Publicado: (2019)

Eliminating tuberculosis in Latin America: making it the point
por: Duarte, Raquel, et al.
Publicado: (2018)

European Union Standards for Tuberculosis Care
por: Migliori, G.B., et al.
Publicado: (2012)

Adverse Events in Healthy Individuals and MDR-TB Contacts Treated with Anti-Tuberculosis Drugs Potentially Effective for Preventing Development of MDR-TB: A Systematic Review
por: Langendam, Miranda W., et al.
Publicado: (2013)

Maintaining Fluoroquinolone Class Efficacy: Review of Influencing Factors
por: Scheld, W. Michael
Publicado: (2003)

Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study
por: Nalunjogi, Joanitah, et al.
Publicado: (2023)

A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populations
por: Mahon, James, et al.
Publicado: (2022)

Identifying components for programmatic latent tuberculosis infection control in the European Union
por: Sandgren, Andreas, et al.
Publicado: (2016)

Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline
por: Kocsis, Béla, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_apnpob7tbl11i1djj3ku832ke5